Dyslipidaemia in adult growth hormone (GH) deficiency and the effect of GH replacement therapy: A review

Trends in Endocrinology and Metabolism

Volumn 9, Issue 5, 1998, Pages 200-206

  Christ, Emanuel R ^a   Cummings, Michael H ^a   Russell Jones, David L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; CHOLESTEROL; CHOLESTEROL ESTER; FATTY ACID; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PLACEBO; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DYSLIPIDEMIA; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0032125903     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(98)00050-2     Document Type: Review

References (61)

1. Angelin B, Rudling M Growth hormone and hepatic lipoprotein metabolism. Curr Opin Lipidol. 5:1994;160-165.
2. Armstrong VM, Cremer P, Eberle Eet al. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis. 62:1986;249-257.
3. Asayama K, Amemiya S, Kusano S, Kato K Growth-hormone induced changes in postheparin and hepatic triglyceride lipase activities. Metabolism. 33:1984;129-131.
4. Attanasio AF, Lamberts SWJ, Matranga AMCet al. Adult growth hormone-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab. 82:1997;82-88.
5. Bates AS, Van't Hoff W, Jones PJ, Clayton RN The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab. 81:1996;1169-1172.
6. Beshyah SA, Freemantle C, Shahi Met al. Replacement therapy with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults. Clin Endocrinol. 42:1995;73-81.
7. Beshyah SA, Henderson A, Niththyananthan Ret al. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. J Clin Endocrinol Metab. 80:1995;356-363.
8. Bostom AG, Cupples LA, Jenner JLet al. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA. 276:1996;544-548.
9. Bülow B, Hagmar L, Mikozy Z, Nordstroem CH, Erfurth EM Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol. 46:1997;75-81.
10. Carroll PV, Christ ER Members of Growth Hormone Research Society Scientific Committee. 1998. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocrinol Metab. 83:1998;382-395.
11. Carroll PV, Umpleby MA, Ward GSet al. rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDD. M. Diabetes. 46:1997;1453-1458.
12. Christ ER, Cummings MH, Albany Eet al. The effect of growth hormone (GH) on VLDL apolipoprotein B100 metabolism in adult GH-deficiency [abst]. Clin Sci. 38(Supp):1997;8.
13. Consensus Conference 1985. Lowering blood cholesterol to prevent heart disease. JAMA 253:2080-2086.
14. Corpas E, Harman SM, Blackman MR Human growth hormone and human aging. Endocr Rev. 14:1993;20-39.
15. Cummings MH, Watts GF, Umpleby AM, Hennessy TR, Quiney JR, Sönksen PH Increased hepatic secretion of very low density lipoprotein apolipoprotein B100 in heterozygous familial hypercholesterolaemia: a stable isotope study. Atherosclerosis. 113:1995;79-89.
16. Cummings MH, Watts GF, Umpleby AMet al. Increased hepatic secretion of very low density lipoprotein apolipoprotein B100 in NIDDM. Diabetologia. 38:1995;959-967.
17. Cummings MH, Christ E, Umpleby AMet al. Abnormalities of very low density lipoprotein apolipoprotein B-100 metabolism contribute to the dyslipidaemia of adult growth hormone deficiency. J Clin Endocrinol Metab. 82:1997;2010-2013.
18. Cuneo RC, Salomon F, Watts GF, Hesp R, Sönksen PH Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabol Clin Exp. 42:1993;1519-1523.
19. Cuneo RC, Judd S, Wallace JDet al. The Australian multicentre trial of growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab. 83:1998;107-116.
20. De Boer H, Blok GJ, Voerman HJ, Phillips M, Schouten JA Serum lipid levels in growth hormone-deficient men. Metabol Clin Exp. 43:1994;199-203.
21. Dixon JL, Ginsberg HN Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. J Lipid Res. 34:1993;167-179.
22. Durrington PN Lipoprotein (a). Bailliere's Clin Endocrinol Metab. 9:1995;773-795.
23. Eden S, Wiklund O, Oscarsson J, Rosen T, Bengtsson BA Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb Vasc Biol. 13:1993;296-301.
24. Einarsson K, Nilsell K, Leijd B, Angelin B Influence of age on secretion of cholesterol and synthesis of bile acids in the liver. New Engl J Med. 313:1985;277-282.
25. Fowelin J, Attvall S, Lager I, Bengtsson BA Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabol Clin Exp. 42:1993;1443-1447.
26. Garry P, Collins P, Devlin JG Lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency. Eur J Endocrinol. 134:1996;61-66.
27. Gibbons GF Assembly and secretion of hepatic very low density lipoprotein. Biochem. J 268:1990;1-13.
28. Goldstein JL, Brown MS Regulation of the mevalonate pathway. Nature. 343:1990;425-430.
29. Heubi JE, Burstein S, Sperling MA, Gregg D, Ravi Subbiah MT, Matthews DE The role of human growth hormone in the regulation of cholesterol and bile acid metabolism. J Clin Endocrinol Metab. 57:1983;885-891.
30. Jansson J-O., Eden S, Isaksson O Sexual dimorphism in the control of GH secretion. Endocr Rev. 6:1985;128-150.
31. Johannsson G, Oscarsson J, Rosen Tet al. Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and Apo(a) and Apo(E) phenotypes. Arterioscler Thromb Vasc Biol. 15:1995;2142-2150.
32. Johannsson G, Bengtsson BA, Andersson B, Isgaard J, Caidahl K Long term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients. Clin Endocrinol. 45:1996;305-314.
33. Kesaniemi YA, Beltz WF, Grundy SM Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease. J Clin Invest. 76:1985;586-595.
34. Kissebah AH, Alfarsi S, Evans DJ, Adams PW Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein B kinetics in non-insulin dependent diabetes mellitus. Diabetes. 31:1982;217-225.
35. Laron Z, Klinger B, Wang XL, Silbergeld A, Wilcken DE Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a). Eur J Endocrinol. 136:1997;377-381.
36. Lehmann ED, Hopkins KD, Weissberger AJ, Gosling RG, Sönksen PH Aortic distensibility in growth hormone deficient adults. Lancet. 341:1993;309.
37. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet. 340:1992;1188-1192.
38. O'Halloran DJ, Wieringa G, Tsatsoulis A, Shalte SM Increased serum lipoprotein(a) concentrations after growth hormone (GH) treatment in patients with isolated GH deficiency. Ann Clin Biochem. 33:1996;330-334.
39. Olivecrona H, Ericsson S, Angelin B Growth hormone treatment does not alter biliary lipid metabolism in healthy adult men. J Clin Endocrinol Metab. 80:1995;1113-1117.
40. Oram JF, Yokoyama S Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res. 37:1996;2473-2491.
41. Oscarsson J, Ottosson M, Johansson JOet al. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity. Metabol Clin Exp. 45:1996;370-377.
42. Ottoson M, Vikman-Adolfsson K, Enerbaeck S, Elander A, Björntorp P, Eden S Growth hormone inhibits lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metab. 80:1995;936-941.
43. Packard JP, Shepherd J Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol. 17:1997;3542-3556.
44. Pfeifer MA, Brunzell JD, Best JD, Judzewitsch RG, Halter JB, Porte D Jr. The response of plasma triglycerides, cholesterol and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridaemia. Diabetes. 32:1983;525-531.
45. Reaven GM Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
46. Rosen T, Bengtsson B-Å Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 336:1990;285-288.
47. Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson B-Å Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol. 129:1993;195-200.
48. Rudling M, Norstedt G, Olivecrona H, Reihner E, Gustafsson JA, Angelin B Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA. 89:1992;6983-6987.
49. Rudling M, Olivecrona H, Eggertsen G, Angelin B Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth-factor I. J Clin Invest. 97:1996;292-299.
50. Rudling M, Parini P, Angelin B Growth hormone and bile acid synthesis. J Clin Invest. 99:1997;2239-2245.
51. Russell-Jones DL, Watts GF, Weissberger Aet al. The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clin Endocrinol. 41:1994;345-350.
52. Salomon F, Cuneo RD, Hesp R, Sönksen PH The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New Engl J Med. 321:1989;1797-1803.
53. Scoppola A, Maher VMG, Thompson GR, Rendell NB, Taylor GW Quantification of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry. J Lipid Res. 32:1991;1057-1060.
54. Sniderman AD, Cianflone K Substrate delivery as a determinant of hepatic apoB secretion. Arterioscler Thromb Vasc Thromb. 13:1993;629-636.
55. Weaver JU, Monson JP, Noonan Ket al. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab. 80:1995;153-159.
56. Webster JM, Stewart M, Al-Maskari Met al. The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein(a) in growth hormone deficient adults. Atherosclerosis. 133:1997;115-121.
57. Whitehead HM, Boreham C, McIlrath EMet al. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol. 36:1992;45-52.
58. Wolthers T, Lemning L, Grofte Tet al. Effects of growth hormone on serum lipids and lipoproteins: possible significance of increased conversion of thyroxine to triiodothyronine. Metabol Clin Exp. 45:1996;1016-1020.
59. Yang S, Xu X, Björntorp P, Eden S Additive effects of growth hormone and testosterone on lipolysis in adipocytes of hypophysectomized rats. J Endocrinol. 147:1995;147-152.
60. Zenobi PD, Graf S, Ursprung H, Froesch RE Effects of insulin-like growth factor-1 on glucose tolerance, insulin levels and insulin secretion. J Clin Invest. 89:1992;1908-1913.
61. Zenobi PD, Jaeggi-Groisman SE, Riesen WF, Roder ME, Froesch ER Insulin-like growth factor-1 improves glucose and lipid metabolism in type 2 diabetes mellitus. J Clin Invest. 90:1992;2234-2241.